The GLCCI1/STAT3 pathway: a novel pathway involved in diabetic cognitive dysfunction and the therapeutic effect of salidroside
Journal of Molecular Histology · 2024
DOI: 10.1007/s10735-024-10236-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Histology, 2024. Verfasst von Lin Niu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Histology and Embryology, Jinzhou Medical University, Jinzhou, 121001, Liaoning, China. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Glucosides, Hippocampus, Phenols. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Foundation of Education Department of Liaoning Province, Natural Science Foundation of Liaoning Province of China.
Abstract (Originalsprache)
Diabetic cognitive dysfunction (DCD) is a complication of diabetes that seriously affects quality of life. Glucocorticoid-induced transcript 1 (GLCCI1) has been found to be involved in inflammation, apoptosis and autophagy in various diseases. However, the distribution of GLCCI1 in the brain and its role in DCD have not yet been revealed. In addition, the potential therapeutics effects of salidroside (SAL), a phenyl propyl glycoside compound known for its neuroprotective effects in treating DCD are unknow. In the present study, we found that GLCCI1 was localized in hippocampal neurons. C57BL/6 J mice with DCD presented downregulation of GLCCI1 and Bcl-2 and upregulation of p-STAT3/STAT3, Bax, Cleaved Caspase-3/Caspase-3. Overexpression of GLCCI1 or SAL administration relieved DCD, reversed the changes in the expression of these cytokines, and alleviated morphological alterations in hippocampal neurons. Interestingly, SAL alleviated DCD and attenuated the expression of GLCCI1 and p-STAT3, showing similar effects as GLCCI1 overexpression. These findings suggest that the GLCCI1/STAT3 axis plays a crucial role in DCD and is involved in SAL-mediated attenuation of DCD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, Histology and Embryology, Jinzhou Medical University, Jinzhou, 121001, Liaoning, China.
- Liaoning Key Laboratory of Diabetic Cognitive and Perceptive Dysfunction, Jinzhou, 121001, Liaoning, China.
- College of Nursing, Physiology, Liaoning Vocational University of Technology, Jinzhou, 121001, Liaoning, China.
- Department of Thoraxes Surgery of the Third Affiliated Hospital, Jinzhou Medical University, Jinzhou, 121001, Liaoning, China.
- The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121001, Liaoning, China.
- Department of Anatomy, Histology and Embryology, Jinzhou Medical University, Jinzhou, 121001, Liaoning, China. liuxuezheng@jzmu.edu.cn.
Förderung
- Foundation of Education Department of Liaoning Province
- Natural Science Foundation of Liaoning Province of China
Zitieren
APA
Niu, L., Xu, M., Liu, W., Yu, H., Yu, S., Li, F., Wang, T., Sun, D., Yao, T., Li, W., Yang, Z., Liu, X., & Zuo, Z. (2024). The GLCCI1/STAT3 pathway: a novel pathway involved in diabetic cognitive dysfunction and the therapeutic effect of salidroside. Journal of Molecular Histology. https://doi.org/10.1007/s10735-024-10236-y
Vancouver
Niu L, Xu M, Liu W, Yu H, Yu S, Li F, et al. The GLCCI1/STAT3 pathway: a novel pathway involved in diabetic cognitive dysfunction and the therapeutic effect of salidroside. Journal of Molecular Histology. 2024. doi:10.1007/s10735-024-10236-y
BibTeX
@article{Niu2024,
author = {Niu, Lin and Xu, Min and Liu, Wenqiang and Yu, Hongdan and Yu, Shengxue and Li, Fuzhi and Wang, Teng and Sun, Die and Yao, Tiefeng and Li, Wanze and Yang, Zhengzhong and Liu, Xuezheng and Zuo, Zhongfu},
title = {The GLCCI1/STAT3 pathway: a novel pathway involved in diabetic cognitive dysfunction and the therapeutic effect of salidroside},
journal = {Journal of Molecular Histology},
year = {2024},
doi = {10.1007/s10735-024-10236-y}
}
EUVIMED